Check out our most popular compounded medications! Get Started
Estriol 0.025%/Testosterone 0.025% Vaginal Gel is a specially compounded medication, designed for easy application in the vaginal area. This gel-like semisolid formulation is used to treat conditions such as Vulvovaginal Atrophy, Dyspareunia, Genitourinary Syndrome of Menopause, Postmenopausal Vaginal Dryness, and Lichen Sclerosus. It combines the therapeutic effects of estriol and testosterone, providing both medication and lubrication for various gynecological purposes.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Estriol 0.025%/Testosterone 0.025% Vaginal Gel is a specially compounded medication designed to address a range of conditions associated with menopause and vulvovaginal atrophy. This includes Atrophic Vaginitis, Vulvovaginal Atrophy, Dyspareunia, Genitourinary Syndrome of Menopause, and Lichen Sclerosus. The gel is a unique blend of estriol and testosterone, two hormones known for their anti-inflammatory properties and their ability to promote the health of vaginal tissue.
Estriol, in this formulation, works to alleviate the symptoms of atrophic vaginitis, which can include dryness, itching, and burning. Testosterone, on the other hand, enhances the elasticity of the vaginal tissue, helping to reduce the discomfort associated with dyspareunia. Together, these hormones work synergistically to mitigate the symptoms of genitourinary syndrome of menopause, such as urinary urgency, frequency, and incontinence. They also provide relief from the symptoms of lichen sclerosus, including itching, burning, and pain.
The Estriol 0.025%/Testosterone 0.025% Vaginal Gel is a gel-like semisolid formulation dispensed in a tube, specifically created for easy and controlled application in the vaginal area. It delivers medication effectively, providing lubrication and therapeutic effects for various gynecological purposes. This formulation is a appropriate treatment for the aforementioned conditions, provided it is used as directed by a healthcare provider.
If you have any questions or concerns about this formulation, please do not hesitate to contact us at Bayview Pharmacy. We are here to provide you with the information and support you need to make informed decisions about your health.
Estriol 0.025%/Testosterone 0.025% Vaginal Gel is a specially compounded formulation designed for the treatment of various gynecological conditions. It is a gel-like semisolid substance that is dispensed in a tube for easy and controlled application in the vaginal area. This formulation is specifically indicated for the treatment of atrophic vaginitis, vulvovaginal atrophy, dyspareunia, genitourinary syndrome of menopause, and lichen sclerosus.
The active ingredients in this formulation are Estriol and Testosterone. Estriol, a weak estrogen, works by reducing inflammation and improving vaginal lubrication. On the other hand, Testosterone, a male hormone, aids in enhancing libido and sexual function. The combination of these hormones in this formulation helps to alleviate symptoms associated with the aforementioned conditions, such as vaginal dryness, itching, burning, and pain.
It is crucial to note that this medication is contraindicated in women who are pregnant or breastfeeding due to the potential risks it may pose. As with any medication, it is important to use this product under the guidance of a healthcare professional. If you have any questions or concerns about this medication, it is recommended to consult with your healthcare provider or pharmacist.
Estriol 0.025%/Testosterone 0.025% Vaginal Gel is a specially compounded medication designed to address a range of gynecological conditions including Atrophic Vaginitis, Vulvovaginal Atrophy, Dyspareunia, Genitourinary Syndrome of Menopause, and Lichen Sclerosus. This unique formulation combines the therapeutic benefits of two hormones, Estriol and Testosterone, which work synergistically to reduce inflammation and promote the health of vaginal tissue.
Estriol, a form of estrogen, is known for its efficacy in alleviating the symptoms of atrophic vaginitis, vulvovaginal atrophy, and dyspareunia. It works by replenishing the estrogen levels in the body, which can decrease due to menopause or other conditions, thereby restoring the health and function of the vaginal tissue.
Testosterone, on the other hand, is instrumental in managing the symptoms of genitourinary syndrome of menopause and lichen sclerosus. It aids in maintaining the elasticity and health of the vaginal and urinary tissues, thereby reducing discomfort and other associated symptoms.
The Estriol 0.025%/Testosterone 0.025% Vaginal Gel is dispensed in a tube and is designed for easy and controlled application in the vaginal area. The gel-like semisolid formulation ensures that the medication is delivered directly to the affected area, providing targeted relief and therapeutic effects. The dosage and frequency of application can vary depending on the severity of the condition and should be used as directed by your healthcare provider.
It is crucial to adhere to the instructions provided by your healthcare provider when using this medication. If you have any queries or concerns regarding the use of Estriol 0.025%/Testosterone 0.025% Vaginal Gel, it is recommended to seek professional advice.
This compounded formulation of Estriol 0.025%/Testosterone 0.025% Vaginal Gel is a specialized medication designed for direct application in the vaginal area. It is a gel-like semisolid substance dispensed in a tube, allowing for easy and controlled application. The formulation is primarily used for the treatment of various gynecological conditions such as Vulvovaginal Atrophy, Dyspareunia, Genitourinary Syndrome of Menopause, Postmenopausal Vaginal Dryness, and Lichen Sclerosus.
Additionally, it may also be beneficial in addressing symptoms such as vaginal itching, burning, and irritation. The therapeutic effects of this formulation may also enhance sexual satisfaction and alleviate pain during intercourse. However, it is crucial to understand that this formulation should not be used to treat any condition other than those specified without the guidance of a healthcare provider.
Patients should be aware that this formulation may cause side effects such as vaginal burning, itching, or irritation. In the event of experiencing any of these side effects, it is recommended to immediately contact a healthcare provider. It is always important to consult with a healthcare provider before starting any new medication, including this Estriol 0.025%/Testosterone 0.025% Vaginal Gel formulation.
This is a gel-like semisolid formulation that is dispensed in a tube. It is specifically created for easy and controlled application in the vaginal area. It delivers medication and provides lubrication and therapeutic effects for various gynecological purposes.
The gel is designed to deliver medication to the vaginal area for various gynecological purposes. It also provides lubrication and therapeutic effects.
The gel is dispensed from a tube and is designed for easy and controlled application in the vaginal area. Always follow the instructions provided by your healthcare provider.
The active ingredients in the gel are Estriol and Testosterone, each at a concentration of 0.025%.
As with any medication, there may be potential side effects. It is important to discuss these with your healthcare provider before starting treatment.
Before using this medication, it is important to discuss with your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding.
Store the gel as directed by your healthcare provider or the product packaging. Typically, it should be stored at room temperature, away from heat and moisture.
If you miss a dose, apply it as soon as you remember. If it is close to the time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not apply two doses at the same time.
Before using other vaginal products, it is important to discuss with your healthcare provider to avoid potential interactions.
If you experience any adverse reactions while using the gel, stop using it and contact your healthcare provider immediately.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
This preparation is a controlled substance. Additional prescribing, refill, and shipping restrictions apply, and the states Bayview can dispense it to are narrower than for non-controlled preparations.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Insert/apply intravaginally
